Adam Simpson is the president and chief executive officer of PvP Biologics. He has substantial life science operational and emerging company experience and has executed significant partnering and acquisition transactions. Prior to joining PvP Biologics as president and CEO, he was the president and chief operating officer of Cypher Genomics, a genome interpretation company focused on biomarker discovery to facilitate drug development, through its sale to Human Longevity, Inc. Previously, Mr. Simpson was a co-founder and chief business officer of Meritage Pharma, a company developing treatments for upper gastrointestinal disorders, from company creation through its staged sale to Shire, and at Verus Pharmaceuticals, a company focused on treatments for asthma and anaphylaxis, where as general counsel he led its sale to AstraZeneca and Shionogi. He has been a co-founder of three additional life sciences companies that have either gone public or been acquired. Mr. Simpson started his career as an attorney at Latham & Watkins. He holds a B.S. in biochemistry from the University of California, San Diego, and received his J.D. from the University of Minnesota Law School.